
About Surmount Laboratories
Surmount Laboratories is a Healthcare company based in Mumbai (India) founded in 1983. It operates as a development, manufacturing, and marketing of pharmaceutical tablets and capsules. The company has 19 employees. Its Indian entity Surmount Laboratories Limited reported revenue of βΉ95.33 Cr. Surmount Laboratories offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Drug Manufacturing, Finished Dosages and Biotechnology.
Company details
Surmount Laboratories is identified as a global pharmaceutical entity that focuses on the development, manufacturing, and marketing of finished dosages such as tablets and capsules. Efforts are made to ensure access to affordable medicines for patients worldwide, with products tailored to various therapeutic segments. The companys operations are based in India, where cutting-edge technology is utilized to address customer needs in healthcare. Commitment is shown to serving health care requirements across different markets, emphasizing quality and innovation in product offerings.
- Headquarters Mumbai, India
- Employees 19
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Legal Name Surmount Laboratories Private Limited
- Date of Incorporation 28 Mar, 1996
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹95.33 Cr
FY 2024 · -6% YoY
- Net Profit₹8.42 Cr
FY 2024 · 9% margin
- EBITDA₹13.33 Cr
FY 2024 · 14% margin
- Employee Count19
Associated legal entities of Surmount Laboratories
Surmount Laboratories is associated with 2 registered companies on The Company Check; the primary company is Surmount Laboratories Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Surmount Laboratories Limited CIN U24230MH1996PLC098511 | Active | 28 Mar 1996 | Mumbai, Maharashtra | ₹95.3 Cr | 19 | 3 | View details |
| Surmount Laboratories Private Limited CIN U24230MH1996PTC098511 | – | 28 Mar 1996 | Mumbai, Maharashtra, India | – | – | – | View details |
Products & Services of Surmount Laboratories
Surmount Laboratories offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are developed and manufactured as finished dosages for different therapeutic segments
Capsules are produced and marketed as finished dosages targeting various therapeutic needs
Board of directors of Surmount Laboratories Limited (Surmount Laboratories)
Surmount Laboratories Limited is the primary company behind Surmount Laboratories. The board of Surmount Laboratories Limited currently have 3 directors; the longest-serving is Minesh Dhirendra Mehta, appointed in 2017. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Minesh Dhirendra Mehta DIN 08008906 | Director | 04 Dec 2017 | 8 yrs 10 mo | Surmount Laboratories Limited |
| Dhirendra Maganlal Mehta DIN 03575117 | Director | 27 Aug 2020 | 6 yrs 1 mo | Surmount Laboratories Limited |
| Kavit Dhirendrakumar Mehta DIN 03575128 | Director | 31 Aug 2022 | 4 yrs 1 mo | Surmount Laboratories Limited |
Financials of Surmount Laboratories
Figures of Surmount Laboratories Limited, the primary company behind Surmount Laboratories, for FY 2024. Revenue was ₹95.33 Cr (-6% year on year). Net profit was ₹8.42 Cr (9% margin). EBITDA was ₹13.33 Cr (14% margin). Revenue has grown at a compounded annual rate of +6% over three years and +8% over five years.
- ₹95.33 CrRevenue · FY 2024 · -6% YoY
- ₹8.42 CrNet profit · 9% margin
- ₹13.33 CrEBITDA · 14% margin
- ₹4.72 CrPaid-up capital
- 19Employees (provident fund records)
- +6%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Surmount Laboratories Limited are on its company page.
Detailed financial statements for Surmount Laboratories
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Surmount Laboratories (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Surmount Laboratories
Surmount Laboratories was founded in 1983.
Surmount Laboratories is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Surmount Laboratories has 19 employees.
The primary company behind Surmount Laboratories, Surmount Laboratories Limited, reported revenue of βΉ95.33 Cr for FY 2024, down 6% year on year.
Surmount Laboratories is identified as a global pharmaceutical entity that focuses on the development, manufacturing, and marketing of finished dosages such as tablets and capsules. Efforts are made to ensure access to affordable medicines for patients worldwide, with products tailored to various therapeutic segments. The companys operations are based in India, where cutting-edge technology is utilized to address customer needs in healthcare. Commitment is shown to serving health care requirements across different markets, emphasizing quality and innovation in product offerings.
Surmount Laboratories offers Tablets and Capsules.
Surmount Laboratories operates through Surmount Laboratories Limited.
The legal entities of Surmount Laboratories currently have 3 directors, including Minesh Dhirendra Mehta, Dhirendra Maganlal Mehta, Kavit Dhirendrakumar Mehta.